Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

22.83 +0.23 (+1.02%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8%
Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. The company’s full-year revenue guidance... 
Via StockStory
Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns. 
Via Benzinga
Exposures Product Safety
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves. 
Via Chartmill
Kwizda Pharma Adopts CARA Life Sciences Platform for Rapid QMS Implementation with Minimal IT Resources
LONDON - April 30, 2025 - PRLog -- Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis, leading... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
Pfizer Has Unreasonable Whiff Of The Marlboro Man
The pharmaceutical company’s therapies protecting against and treating Covid-19 are less crucial as the pandemic ebbs, and further products will also eventually be open to competition. 
Via Talk Markets
Exposures COVID-19
Why BioNTech Stock Got Trounced on Tuesday
Via The Motley Fool
Exposures COVID-19
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing. 
Via Benzinga
Exposures Product Safety
Looking for the most active stocks in the S&P500 index on Tuesday?
Looking for the most active stocks in the S&P500 index on Tuesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Zoetis’s (NYSE:ZTS) Q1: Beats On Revenue, Full-Year Sales Guidance is Optimistic
Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.4% year on year to $2.22 billion. The company’s full-year revenue guidance... 
Via StockStory
Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns
President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new... 
Via Benzinga
Topics Government World Trade
Exposures Political Product Safety Tariff
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April
Via The Motley Fool
Exposures Product Safety
BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
BioNTech's Q1 revenue hit $192 million, beating estimates; company confirms 2025 outlook and names new CFO ahead of oncology-focused expansion. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Exposures US Equities
Where Will Viking Therapeutics Be in 3 Years?
Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years. 
Via The Motley Fool
Topics Bankruptcy
Exposures Financial Legal
3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May
Three supercharged income stocks -- sporting an average yield of 8.63% -- are perfectly positioned to fatten investors' pocketbooks. 
Via The Motley Fool
Topics World Trade
Exposures COVID-19 Tariff
1 Safe-and-Steady Stock to Target This Week and 2 to Be Wary Of
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows
AES Corp., Pfizer, and LyondelBasell are examples of stocks offering a high-yield dividend today and potential upside in the latter half of 2025 
Via MarketBeat
Topics Economy Energy Government
Exposures Coal Economy Electricity Generation
US Stock Futures Rise As Meta, Microsoft Earnings Fuel Optimism: GDP Slump Linked To Tariff Anticipation, Not Recession, Says Analyst
U.S. stock futures rose early Thursday morning, following the robust earnings of two "Mag 7" companies after markets closed on Wednesday. 
Via Benzinga
Topics Economy
Exposures Economy
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.
There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are hiding in plain sight. 
Via The Motley Fool
Topics Bonds World Trade
Exposures COVID-19 Debt Markets Tariff
Could Pfizer’s 7.1% Yield Be A Trap?
It’s easy to understand why income investors are interested in Pfizer. With a current yield of 7.1%, it’s one of the highest-yielding stocks in the S&P 500. Let’s dig into the dividend and see whether... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Pfizer CEO Albert Bourla Emphasizes National Security In US Drug Manufacturing
Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations and national security concerns. 
Via Benzinga
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
Setting Goals: How to Navigate a Chronic Inflammatory Disease
(BPT) - Content sponsored and provided by Pfizer. Ashley partnered with Pfizer to share her experience living with moderate to severe rheumatoid arthritis (RA). 
Via Brandpoint
Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul
Via The Motley Fool
Topics World Trade
Exposures Tariff
This High-Yield Pharma Stock Looks Like an Incredible Bargain
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Pfizer's Dividend Yield Is 7.5%. Is It Still Safe?
Via The Motley Fool
Topics World Trade
Exposures Tariff
US Stock Futures Fall After Tuesday Rally, But History Favors Bulls: Markets Rose 9 Of Last 10 Mays, Says Expert
U.S. stock futures are down Wednesday morning, despite major averages ending up on Tuesday, and the S&P 500 and Dow Jones notching their sixth-straight day in the green, the longest streak for the... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.